KEYTRUDA QLEX 2000 U/mL (Pembrolizumab and Berahyaluronidase Alfa-Pmph INJECTION, SOLUTION) 2000 U/mL

KEYTRUDA QLEX 2000 U/mL is a subcutaneous injection solution combining pembrolizumab and berahyaluronidase alfa-pmph. This medication is used in cancer treatment to help the immune system fight cancer cells. Learn more about KEYTRUDA QLEX 2000 U/mL and its uses.

Strength

2000 U/mL

Pack Size

1 VIAL in 1 CARTON (0006-5083-01) / 4.8 mL in 1 VIAL (0006-5083-99)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

KEYTRUDA QLEX 2000 U/mL is primarily used in cancer treatment. It works by helping the immune system recognize and attack cancer cells. This medication is often prescribed for various types of cancer, including melanoma, lung cancer, and others. The combination of pembrolizumab and berahyaluronidase alfa-pmph aims to enhance the body's natural defenses against cancer.

Side Effects

Common effects of KEYTRUDA QLEX 2000 U/mL may include fatigue, nausea, and skin reactions at the injection site. Some individuals may experience more severe side effects, such as immune-related adverse events. It is important to discuss any unusual symptoms with a healthcare provider.

Precautions & Warnings

KEYTRUDA QLEX 2000 U/mL should be handled with care. It is important to follow the storage and administration instructions provided by the healthcare provider. This medication should not be used without medical supervision. Always inform your healthcare provider about any other medications you are taking.

Avoid Interactions

KEYTRUDA QLEX 2000 U/mL may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain supplements may also interact with this medication.

Frequently Asked Questions

KEYTRUDA QLEX 2000 U/mL is used in cancer treatment to help the immune system fight cancer cells.

KEYTRUDA QLEX 2000 U/mL is administered as a subcutaneous injection.

Common side effects may include fatigue, nausea, and skin reactions at the injection site.

It is important to discuss all current medications with your healthcare provider to avoid potential interactions.

If you experience severe side effects, contact your healthcare provider immediately.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.